ARDS患者支气管肺泡灌洗液宏基因组测序的肺部微生物组分析:一项回顾性观察研究
该回顾性研究纳入159例ARDS患者,用机器学习分类器分为低炎症型(n=92)和高炎症型(n=67),比较BALF的mNGS与常规微生物检测及肺部微生物组组成。高炎症型院内死亡率65.7% vs 30.4%(P<0.001),28天死亡率53.7% vs 22.8%(P<0.001)。mNGS在18.2%常规检测阴性病例中检出病原,病毒检出74.5% vs 28.2%(P<0.001),混合感染74.5% vs 41.1%(P<0.001)。高炎症型物种丰富度显著降低(Chao1 P<0.001;ACE P=0.001),调整后仍显著。
要点
- 高炎症型ARDS院内死亡率65.7% vs 低炎症型30.4%(P<0.001),28天死亡率53.7% vs 22.8%(P<0.001)。
- mNGS在18.2%常规微生物检测阴性病例中检出病原,常规检测仅在2.5% mNGS阴性病例中检出病原。
- mNGS病毒检出率74.5% vs 常规28.2%(P<0.001),混合感染检出74.5% vs 41.1%(P<0.001)。
- 高炎症型物种丰富度显著降低(Chao1 P<0.001;ACE P=0.001),完全调整年龄、性别、免疫抑制后仍显著(Chao1 P=0.002;ACE P=0.003)。
- 高炎症型富集肺炎克雷伯菌、嗜肺军团菌和甲型流感H1N1,低炎症型富集嗜麦芽窄食单胞菌和疱疹病毒。
适用人群与场景
- 回顾性纳入159例ARDS患者,分为低炎症型(n=92)和高炎症型(n=67),采集支气管肺泡灌洗液(BALF)进行分析。
- 原文未提及具体的纳入/排除标准、急诊/ICU/院前场景及病情阶段。
诊断标准与关键阈值
- 使用已验证的机器学习分类器将ARDS患者分为低炎症型和高炎症型,原文未提及具体分类器名称、评分界值或阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性观察研究;样本量:159例ARDS患者;单中心或多中心原文未提及。
- 干预/暴露:BALF行mNGS和常规微生物检测(CMT),比较两组临床特征、病原谱和肺部微生物组组成。
- 主要终点结果:高炎症型院内死亡率65.7% vs 30.4%(P<0.001),28天死亡率53.7% vs 22.8%(P<0.001)。
- mNGS诊断性能:18.2%的CMT阴性病例由mNGS检出病原,仅2.5%的mNGS阴性病例由CMT检出病原;病毒检出74.5% vs 28.2%(P<0.001),混合感染74.5% vs 41.1%(P<0.001)。
- 微生物组:高炎症型物种丰富度降低(Chao1 P<0.001;ACE P=0.001),调整ARDS病因分类和肺/肺外ARDS后基本不变,完全调整年龄、性别、免疫抑制后仍显著(Chao1 P=0.002;ACE P=0.003);均匀度指数(Shannon/Simpson)和β多样性(PERMANOVA P=0.156)无差异。
- 病原分布:两组均以鲍曼不动杆菌最常见;高炎症型富集肺炎克雷伯菌、嗜肺军团菌和甲型流感H1N1,低炎症型富集嗜麦芽窄食单胞菌和疱疹病毒。
- LEfSe分析:高炎症型富集Bifidobacterium dentium和Gemella sanguinis,低炎症型富集Streptococcus mitis等共生菌;网络分析显示病原与共生菌之间存在正负相关。
证据类型、等级与局限
- 证据类型:回顾性观察研究;证据等级或推荐强度原文未提及。
- 局限:回顾性设计、单中心(原文未明确说明多中心)、样本量159例、观察性关联不能推断因果。
对床旁实践的改变
- 对于ARDS患者,mNGS可提高病原检出(尤其病毒和混合感染),在常规检测阴性时仍可能检出病原(18.2%),可考虑用于病因未明的ARDS。
- 高炎症型ARDS患者病情更重、死亡率更高,需更积极监护和救治;但原文未提供基于微生物组的治疗干预方案。
- 肺部微生物组物种丰富度降低与高炎症型相关,但原文未将其作为决策阈值,需前瞻性验证。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute respiratory distress syndrome (ARDS) exhibits significant clinical heterogeneity, with inflammatory subphenotypes (hypoinflammatory and hyperinflammatory) representing a key axis for precision medicine. The role of the pulmonary microbiome in these subphenotypes remains poorly understood.
METHODS: This retrospective study enrolled 159 ARDS patients. Using a validated machine-learning classifier, patients were stratified into hypoinflammatory (n=92) and hyperinflammatory (n=67) groups. Bronchoalveolar lavage fluid (BALF) was analyzed by metagenomic next-generation sequencing (mNGS) and conventional microbiological testing (CMT). Clinical characteristics, pathogen profiles, and pulmonary microbiome composition were compared between groups.
RESULTS: Patients in the hyperinflammatory phenotype had more severe disease, with significantly higher in-hospital mortality (65.7% vs. 30.4%, P < 0.001) and 28-day mortality (53.7% vs. 22.8%, P < 0.001). mNGS demonstrated superior diagnostic performance, identifying pathogens in 18.2% of cases that were negative by conventional microbiological testing (CMT), whereas CMT alone detected pathogens in only 2.5% of mNGS-negative cases. mNGS showed significant advantages in viral detection (74.5% vs. 28.2%, P < 0.001) and in the identification of mixed infections (74.5% vs. 41.1%, P < 0.001). Acinetobacter baumannii was the most prevalent species in both phenotypes; however, the hyperinflammatory phenotype was enriched for Klebsiella pneumoniae, Legionella pneumophila, and influenza A (H1N1), whereas Stenotrophomonas maltophilia and herpesviruses were more prevalent in the hypoinflammatory phenotype. Species richness was significantly reduced in the hyperinflammatory phenotype (Chao1, P < 0.001; ACE, P = 0.001). In adjusted analyses, this association remained virtually unchanged after adjustment for ARDS etiological category and pulmonary vs. extrapulmonary ARDS, and remained significant in the fully adjusted model additionally accounting for age, sex, and immunosuppression (Chao1: P = 0.002; ACE: P = 0.003). Evenness indices (Shannon/Simpson) and overall community structure (β-diversity; PERMANOVA, P = 0.156) did not differ between phenotypes, suggesting a selective depletion of rare, low-abundance taxa rather than a global restructuring of the pulmonary microbiota. Linear discriminant analysis effect size (LEfSe) identified differentially abundant taxa of exploratory significance: the hyperinflammatory phenotype was enriched for Bifidobacterium dentium and Gemella sanguinis, whereas the hypoinflammatory phenotype was enriched for commensals such as Streptococcus mitis. Network analysis revealed well-defined positive and negative correlations between pathogens and commensal taxa.
CONCLUSIONS: The hyperinflammatory phenotype of ARDS is characterized by greater clinical severity and a distinct pulmonary microbiome signature. Metagenomic next-generation sequencing (mNGS) substantially outperforms conventional methods for etiological diagnosis. LEfSe analysis identified differentially enriched taxa, with the hyperinflammatory phenotype enriched for microorganisms that typically colonize the oral cavity or gut (e.g., Bifidobacterium dentium), suggesting potential microbial translocation along the oral-lung or gut-lung axis. These findings provide a novel microbiome dimension for the precision subphenotyping of ARDS.
参考来源
- Gao X, Qin R, He J, et al. Analysis of the pulmonary microbiome in ARDS patients using bronchoalveolar lavage fluid metagenomic next-generation sequencing: a retrospective observational study. J Intensive Care. 2026. PMID: 42711738. doi:10.1186/s40560-026-00940-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。